Skip to main content

Author: Editor

ICF Vaccine

The CT-college recently published a template for informed consent form (ICF), that can be used for interventional clinical trials with an investigational vaccine in adult healthy volunteers.

Read more.

If you would like to read more about this, please consider becoming a Barec-member and acquire access to our member area.
Please contact us for more information on becoming a member via: info@barec.be

Guidance for e-ICF

The CT-college recently published the following guidance on its website. This document describes the restrictions that should be taken into account when using electronic methods to inform a potential participant of a clinical trial and/or to have the ICF signed.

Link: Guidance for sponsors on the use of electronic informed consent in interventional clinical trials in Belgium.

If you would like to read more about this, please consider becoming a Barec-member and acquire access to our member area.
Please contact us for more information on becoming a member via: info@barec.be

 

30/10/2020

 

Biobank biannual evaluation.

Online information session organized by BAREC WG biobank and BBMRI.be (members only)

 

If you would like to read more about this, please consider becoming a Barec-member and acquire access to our member area.

Evaluation of Biobanks

Evaluation of Biobanks

In addition to the initial submission form, the BAREC WG for biobanks has developed and finalized a document that aims to support the ethics committees performing the biannual evaluation of biobanks.  

EC Submission form for Biobanks

EC Form for Biannual Evaluation of Biobanks

If you would like to read more about this, please consider becoming a Barec-member and acquire access to our member area.
Please contact us for more information on becoming a member via: info@barec.be

 

ICF interventional trials

On its latest general assembly, BAREC agrees on a statement concerning the section “trial at a glance” of the model ICF for interventional clinical trials with IMP adults.

Read more.

ICF – Trial at a glance

On 3/9/2020, the general assembly of BAREC agrees on the following statement regarding the section “trial at a glance” of the ICF template for interventional clinical trials with IMP on adult patients:

Continue reading

03/09/2020

BAREC General Assembly

Members only.
September 3rd, 2020

 

If you would like to read more about this, please consider becoming a Barec-member and acquire access to our member area.
Please contact us for more information on becoming a member via: info@barec.be

 

Membership board clinical trials college

A call for membership of the college for clinical trials has recently been published by the CT college.  

Would you like to become a member of the Board of the Clinical Trials College?

The Clinical Trials College is looking for physicians, lawyers, and experts in quality control systems. For more information about the mission, tasks and competences of the College, the law, and its decrees, please visit www.ct-college.be.

A call to candidates was published in the Belgian Official Gazette on 03/08/2020:

https://overlegorganen.gezondheid.belgie.be/sites/default/files/documents/290583_ka_pub.pdf

If you meet the described conditions, you can send your application by registered letter to the federal Minister of Health, through Mr. Pedro Facon, Director-General of Healthcare, Eurostation, Blok II, Place Victor Horta 40, box 10, 1060 Brussels and this at the latest two months after publication of the call to candidates in the Belgian Official Gazette.

European Guidance: UPDATE

Today an updated version of the European guidance was published on EudraLex10:
https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/guidanceclinicaltrials_covid19_en.pdf

The related press release announcing the publication can be found here: https://ec.europa.eu/commission/presscorner/detail/en/ip_20_759

The new version contains additional or new information about:

  • distributor to trial participant IMP shipment,
  • monitoring,
  • remote source data verification and
  • communication with authorities

2nd version European Guidance

Please find an updated version of the European guidance was published on EudraLex-10.

Go to document

The aim is to provide sponsors and investigators with guidance on how to mitigate the effects of the pandemic in order to protect the safety, well-being and integrity of trial participants and the integrity of the trial.

The new version contains additional or new information about:

  • Informed consent in trials with COVID-19 patients;
  • IMP transfer and stocks with patients or at sites;
  • Communication with authorities of temporary trial halts due to reasons which are unrelated to the safety of the trial participants;
  • Stocks of in critical vitro diagnostics and other medical devices used in a particular trial;
  • Safety reporting